(lp0
S"Company Update : Endocyte, Inc. and Seattle Children's Research ... Smarter Analyst - Mar 10, 2017 Endocyte, Inc.  announced their plan to collaborate with Seattle Children's Research Institute and Dr.Endocyte, Inc.  Files An 8-K Results of Operations and Financial ... - Market ExclusiveEndocyte  Reports a Wider Q4 Loss - Yahoo Finance"
p1
aS'Endocyte: A Must Buy While Wall Street Goes Insane Seeking Alpha - Jan 21, 2016 During past few months, while the whole biotech sector has been melting down, Endocyte  has been no exception.'
p2
aS'Endocyte to Present at the IASLC 17th World Conference on Lung Cancer GlobeNewswire  - Dec 1, 2016 WEST LAFAYETTE, Ind., Dec. 01, 2016  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that data&nbsp;...'
p3
aS'Hot Stocks Among Investors: Endocyte, Inc. , Electro Scientific ... Post Analyst - 17 hours ago Endocyte, Inc. has a consensus outperform rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 3.82% of shares outstanding.'
p4
aS'Company Update : Endocyte, Inc. Presents Data on Two Lead ... Smarter Analyst - Oct 10, 2016 Endocyte, Inc.  presented poster updates on its two lead clinical programs at the ESMO 2016 Congress, being held in Copenhagen, Denmark October 7-11, 2016.'
p5
aS'Endocyte Inc.  Plunges 7.25% on March 14 Equities.com - Mar 14, 2017 Endocyte Inc.  had a rough trading day for Tuesday March 14 as shares tumbled 7.25%, or a loss of $-0.19 per share, to close at $2.43.Endocyte  Reports Wider-than-Expected Loss in Q4 - Yahoo FinanceEndocyte, Inc.  Releases Quarterly Earnings Results, Misses Estimates By ... - BNB Daily '
p6
aS"Endocyte  to Post Q4 Earnings: What's in the Cards? Yahoo Finance - Feb 23, 2017 Endocyte, Inc ECYT is expected to report fourth-quarter 2016 results on Mar 1. The company has an impressive track record, having beaten estimates on three of the trailing four quarters and reporting in-line results in the remaining quarter."
p7
aS'Endocyte Inc.  Soars 7.38% on March 13 Equities.com - Mar 13, 2017 Endocyte Inc.  had a good day on the market for Monday March 13 as shares jumped 7.38% to close at $2.62. About 456,348 shares traded hands on 1,523 trades for the day, compared with an average daily volume of 225,466 shares out of a total&nbsp;...'
p8
aS"Endocyte Appoints Mike Sherman as President and Chief Executive Officer GlobeNewswire  - Jun 20, 2016 WEST LAFAYETTE, Ind., June 20, 2016  -- Endocyte, Inc. , a leader in developing targeted small molecule drug conjugates  and companion imaging agents for personalized therapy, today announced that Mike&nbsp;...After failures and partnership breaks, Endocyte CEO retires - FierceBiotechMike Sherman '88 Named President &amp; CEO of Endocyte - DePauw University"
p9
aS'Form S-8 POS ENDOCYTE INC StreetInsider.com - Mar 14, 2017 Endocyte, Inc.  has filed this Post-Effective Amendment No. 4 to Form S-8 Registration Statement  to deregister certain securities issuable under the Endocyte, Inc. 1997 Stock Plan (the &quot;1997 Plan ...'
p10
a.